• Monoclonal antibody decreases asthma attacks by 27% in children and adolescents of color

    1 month ago - By News Medical

    A monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone to asthma attacks and live in low-income urban neighborhoods, a National Institutes of Health clinical trial has found.
    Read more ...